No insider purchase over the last 90 days. The latest was filed 24 Jun 2024.
Every trade that managers of NextPlat Corp disclose to SEC (Form 4) is tracked on this page. The company sits in the Technology sector. The last twelve months, up to 18 October 2026, brought 20 filings signed by 7 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
With 20 filings in twelve months, the company is quieter than the median of 22 filings across the 5,458 companies we follow on the same exchange. Our records for NextPlat Corp go back to 2021, with 10 purchases and no sales on the open market in total.
No insider has bought NextPlat Corp shares on the open market in the past twelve months. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 6 days. Section 16 rules allow two business days to file each Form 4.
Elsewhere in the same sector, our signals recently picked up insider purchases at Gitlab Inc. and Baozun Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 53 declarations
NextPlat Corp is a U.S.-listed company trading on the Nasdaq market (NASDAQ: NXPL, NXPLW), placing it squarely in the NYSE/Nasdaq listed-universe, with headquarters in Hallandale Beach, Florida, United States. For French-speaking investors, the company can be viewed as a hybrid growth platform operating at the intersection of e-commerce, healthcare services, and satellite communications. NextPlat presents itself as a global consumer products and services company, using online storefronts, marketplaces, and retail channels to distribute products and services across the U.S. and international markets. ([ir.nextplat.com](https://ir.nextplat.com/?utm_source=openai))
The company’s roots go back to its former identity as Orbsat Corp, and market sources indicate an initial corporate history dating to 1997, while its modern operating footprint was built over time around international e-commerce and satellite communications. NextPlat adopted its current name in 2022. Its platform has been expanded through acquisitions and strategic integrations, notably Progressive Care, which strengthened the healthcare segment, and Outfitter Satellite, which broadened exposure to satellite-enabled products and services in North America. ([stockanalysis.com](https://stockanalysis.com/stocks/nxpl/company/?utm_source=openai))
Operationally, NextPlat now reports three core business lines: healthcare, satellite communications, and global e-commerce. In healthcare, its PharmcoRx subsidiary offers retail pharmacy, 340B program management, and long-term care services. In satellite communications, subsidiaries GTC, OSAT, and OSI provide satellite-enabled voice, data, tracking, and IoT solutions. In global e-commerce, the company helps brands expand online via major marketplaces and Amazon stores, while also supporting international expansion into China through platforms such as Tmall, JD, and Alibaba. The company also highlights global distribution capabilities for customers in the United States and abroad. ([nextplat.com](https://www.nextplat.com/pages/about-us?utm_source=openai))
NextPlat’s competitive positioning is unusual in that it combines digital commerce execution, healthcare distribution, and satellite connectivity in one corporate structure. That diversification can create multiple growth levers, but it also increases integration complexity and makes execution quality critical. Management states that the company serves more than 150,000 customers across 160+ countries and operates through 30+ storefronts, marketplaces, and retail locations, underscoring a meaningful international footprint for a relatively small-cap listed company. ([nextplat.com](https://www.nextplat.com/pages/about-us?utm_source=openai))
Recent developments have centered on turnaround execution and margin improvement. NextPlat reported $65.5 million of consolidated revenue for fiscal 2024 and $54 million of revenue for fiscal 2025, while also emphasizing cost-cutting, refocusing initiatives, and efforts to improve operational profitability. Quarterly disclosures in 2025 and 2026 pointed to improving performance in healthcare and better sequential trends. For investors in the U.S. market, the key question is whether NextPlat can translate its diversified asset base into sustained revenue quality, stronger margins, and eventually more predictable free cash generation. ([nasdaq.com](https://www.nasdaq.com/press-release/nextplat-reports-655-million-consolidated-year-end-2024-revenue-2025-03-24?utm_source=openai))
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 6 filings published between 15 October and 16 October 2026: no open-market purchase or sale filed by an insider. 6 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 17 October 2026 (UTC)